AstraZeneca's China President, Leon Wang, is under investigation by Chinese authorities.

AstraZeneca's China President, Leon Wang, is under investigation by Chinese authorities, as confirmed by the company. Wang is cooperating, and AstraZeneca's operations in China remain stable under a new general manager. The investigation has led to a significant drop in AstraZeneca's shares, making it the largest loser on London's FTSE 100. The company has not disclosed details about Wang's status or the investigation's nature.

October 30, 2024
25 Articles